Literature DB >> 12119802

Hypertension in orthostatic hypotension and autonomic dysfunction.

Italo Biaggioni1, Rose Marie Robertson.   

Abstract

Disabling orthostatic hypotension dominates the clinical picture of autonomic failure. Nonetheless, severe supine hypertension is observed in about 50% of patients. In patients with multiple system atrophy (Shy-Drager syndrome), supine hypertension is explained by residual sympathetic tone because it can be eliminated with the ganglionic blocker trimethaphan. The cause of hypertension in patients with pure autonomic failure is not known and its understanding may be relevant to essential hypertension. Supine hypertension complicates the treatment of these patients but can be managed by overnight administration of antihypertensive medications.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  2002        PMID: 12119802     DOI: 10.1016/s0733-8651(01)00005-4

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  28 in total

Review 1.  Neurocardiology: therapeutic implications for cardiovascular disease.

Authors:  David S Goldstein
Journal:  Cardiovasc Ther       Date:  2010-11-25       Impact factor: 3.023

Review 2.  Current concepts in orthostatic hypotension management.

Authors:  Amy C Arnold; Cyndya Shibao
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

3.  Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension.

Authors:  Luis E Okamoto; Alfredo Gamboa; Cyndya A Shibao; Amy C Arnold; Leena Choi; Bonnie K Black; Satish R Raj; David Robertson; Italo Biaggioni
Journal:  Hypertension       Date:  2014-09-29       Impact factor: 10.190

Review 4.  Management approaches to hypertension in autonomic failure.

Authors:  Amy C Arnold; Italo Biaggioni
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-09       Impact factor: 2.894

Review 5.  Orthostatic Circulatory Disorders: From Nosology to Nuts and Bolts.

Authors:  Michael Gutkin; Julian M Stewart
Journal:  Am J Hypertens       Date:  2016-04-01       Impact factor: 2.689

Review 6.  Orthostatic hypotension: framework of the syndrome.

Authors:  Jochanan E Naschitz; Itzhak Rosner
Journal:  Postgrad Med J       Date:  2007-09       Impact factor: 2.401

7.  Clinical characteristics of supine hypertension in de novo Parkinson disease.

Authors:  Tadashi Umehara; Hiromasa Matsuno; Chizuko Toyoda; Hisayoshi Oka
Journal:  Clin Auton Res       Date:  2015-11-27       Impact factor: 4.435

8.  Management of hypertension in the setting of autonomic dysfunction.

Authors:  Cyndya Shibao; Alfredo Gamboa; André Diedrich; Italo Biaggioni
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

9.  Hypertension increases cerebral 6-18F-fluorodopa-derived radioactivity.

Authors:  David S Goldstein; Courtney Holmes; Latoya Sewell; Irwin J Kopin
Journal:  J Nucl Med       Date:  2009-08-18       Impact factor: 10.057

10.  Increased superoxide levels in ganglia and sympathoexcitation are involved in sarafotoxin 6c-induced hypertension.

Authors:  Melissa Li; Xiaoling Dai; Stephanie Watts; David Kreulen; Gregory Fink
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-03       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.